- Call MSU: (517) 355-1855|
- Visit: msu.edu|
- Notice of Nondiscrimination|
SPARTANS WILL|© Michigan State University|
(Updated July 8th 2026)
| Title/Description | Sponsor | PI | Amount | Start Date | End Date |
|---|---|---|---|---|---|
| Reproductive and Developmental Sciences Program T32 Training Grant | NIH | Keith Latham, PhD Asgi Fazleabas, PhD | $1,485,595 | 6/1/16 | 4/30/27 |
| A Smartphone Intervention for Pregnancy Smoking Cessation with Peer Support | NIH | Cristian Meghea, PhD | $751,923 | 8/6/20 | 8/31/26 |
| Regulation of Endometriotic Lesion Development by NOTCH1 | NIH | Asgerally Fazleabas, PhD | $2,757,437 | 4/1/21 | 2/28/27 |
| Epigenetic regulatory mechanisms and therapeutic opportunities in endometriosis | NIH | Ronald Chandler, PhD | $1,682,375 | 8/15/21 | 6/30/26 |
| A Smartphone Intervention for Pregnancy Smoking Cessation with Peer Support | NIH | Cristian Meghea, PhD | $567,744 | 9/1/22 | 8/31/26 |
| Signaling Mechanisms that Modulate Uterine 3D Structure for Pregnancy Success | NIH | Ripla Arora, PhD | $1,984,108 | 9/1/22 | 5/31/27 |
| The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer | Univ of Missouri - NIH | Ripla Arora, PhD | $204,209 | 9/23/22 | 1/31/27 |
| Developing a clinically-relevant genetically engineered mouse model for Nut carcinoma | NIH - NCI | Bin Gu, PhD | $2,145,235 | 1/5/23 | 12/31/27 |
| SIRT1 as a Therapeutic Target in Endometriosis | NIH - Duke University | Ripla Arora, PhD | $59,353 | 8/1/23 | 7/31/26 |
| Maternal Health Multilevel Intervention/s for Racial Equity (MIRACLE) Center | NIH - NICHD | Cristian Meghea, PhD Jennifer Johnson, PhD | $18,494,512 | 8/17/23 | 7/31/30 |
| Alternative Splicing Rewiring by Neurofibromin Isoforms Through ER-alpha and RAS Dependent Mechanisms | NIH | Patrick Dischinger, PhD | $414,122 | 9/1/23 | 7/31/29 |
| All of Us Research Program Trans-America Consortium of the HCSRN | NIH | Christine Cole Johnson, PhD | $23,933,034 | 9/1/23 | 8/31/26 |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Jennifer Straughen, PhD | $2,143,971 | 9/1/23 | 5/31/30 |
| Long Term Effectiveness of Uterine Sparing Fibroid Treatments | NIH | Ganesa Wegienka, PhD | $600,632 | 9/1/23 | 8/31/27 |
| New Horizons in the prevention and treatment of Food Allergy - SUNBEAM | Johns Hopkins University | Christine Cole Johnson, PhD | $1,446,208 | 4/4/24 | 2/28/31 |
| Strong Beginnings (Healthy Start Initiative – Eliminating Racial/Ethnic Disparities) | HRSA - Spectrum Health System | LeeAnne Roman, PhD | $91,667 | 5/1/24 | 3/31/27 |
| Partnering for Equity: An Academic and Community Alliance to Eliminate Disparities throughout the Fibroid Experience (PEACE) | NIH - Univ of Michigan | Ganesa Wegienka, PhD | $1,812,533 | 5/1/24 | 1/31/29 |
| Developing a baboon model for uterine fibroids | NIH - NICHD | Jose Teixeira, PhD | $431,750 | 8/1/24 | 7/31/26 |
| Noninvasive and early detection of endometriosis using a biological neural circuit-based novel gas sensor | NIH - NICHD | Asgerally Fazleabas, PhD | $426,214 | 8/7/24 | 8/6/26 |
| A Longitudinal Study of the Epidemiology of Endometriosis | Department of Defense | Madhavi Kulkarni, PhD | $312,998 | 8/15/24 | 8/14/26 |
| Understanding the functional role of fibroid subtype mutations for drug discovery | NIH - NICHD | Emmanuel Paul, PhD | $235,934 | 9/1/24 | 8/31/26 |
| Environmental risk factors for uterine fibroids: a prospective ultrasound study | NIH | Ganesa Wegienka, PhD | $622,163 | 9/1/24 | 8/31/26 |
| Child Health and Human Development Extramural Research | NIH | Ganesa Wegienka, PhD | $446,399 | 9/5/24 | 8/31/26 |
| MI CARES Expansion | DHHS - SAMHSA | Cara Poland, MD | $900,000 | 9/30/24 | 9/29/27 |
| Role of the HTR3A serotonin receptor in high grade endometrial cancer | Corewell Health - MSU Alliance | John Risinger, PhD | $165,027 | 2/1/25 | 7/31/26 |
| Mechanisms underlying Developmental Lung Disease in a TBX4 Syndrome model | Pulmonary Hypertension Association | Ripla Arora, PhD | $65,000 | 4/10/25 | 4/10/26 |
| A Community-Clinical Partnered Care Model to Advance Maternal Health Equity | MSU Health Equity Research Funding Opportunity | Xiao Yu, PhD | $75,000 | 4/15/25 | 10/14/26 |
| Obesity-induced endometrial stromal cell fibrosis and immunosuppression leads to increased endometrial hyperplasia disease severity | NIH - NICHD | Hilary Skalski | $127,398 | 5/16/25 | 5/15/28 |
| The impact and reversibility of obesity-induced molecular and functional alterations to the human endometrium | NIH - Univ of Michigan | Jose Teixeira, PhD | $233,610 | 6/1/25 | 5/30/30 |
| A US-UK Collaborative Study of the Health of Children Born From In Vitro Fertilization: From Conception through Young Adulthood | NIH - Emory Univ | Barbara Luke, ScD | $200,689 | 6/1/25 | 5/31/26 |
| Developing a Dre-rox Recombination-Based Genetically Engineered Mouse Model (GEMM) for NUT Carcinoma | NIH - NCI | Bin Gu, PhD | $153,278 | 7/3/25 | 6/30/27 |
| Disparities in maternal health and healthcare among Medicaid-insured mothers with disabilities | Blue Cross Blue Shield of Michigan Foundation | Hannah Bolder, PhD | $50,000 | 9/1/25 | 2/28/27 |
| Understanding endometrial tissue field defects in obesity-related endometrial hyperplasia | NIH | Ronald Chandler, PhD | $1,394,304 | 9/1/25 | 8/31/27 |
| Transcriptomic Changes during early endometriotic lesion development | NIH | Gregory Burns, PhD | $3,402,652 | 9/12/25 | 8/31/30 |
| State Opioid Relief for Use Disorders | MDHHS | Cara Poland, MD | $1,200,000 | 10/1/25 | 9/30/26 |
| Strong Beginnings: Reaching Black and Hispanic Women at Greatest Risk to Improve Outcomes | MDHHS | Lee Anne Roman, PhD | $753,678 | 10/1/25 | 9/30/26 |
| Addiction Medicine Curriculum | MDHHS | Cara Poland, MD | $882,486 | 10/1/25 | 9/30/29 |
| Tailoring enhanced prenatal care to advance maternal health: Social risk complexity and severe maternal morbidity among Medicaid enrollees | Blue Cross Blue Shield of Michigan Foundation | Xiao Yu, PhD | $40,000 | 11/19/25 | 5/18/27 |
| Develop a human pluripotent stem cell-derived preclinical model for NUT Carcinoma | NIH - NCI | Bin Gu, PhD | $157,000 | 6/1/26 | 5/31/28 |
If you're having accessibility issues, please let us know.
SPARTANS WILL|© Michigan State University|